2019
Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation
Beech C, Freedman-Weiss M, Salem R, Jain D, Zhang X. Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation. Gastroenterology Research 2019, 12: 185-190. PMID: 31523327, PMCID: PMC6731045, DOI: 10.14740/gr1201.Peer-Reviewed Original ResearchCarcinoembryonic antigen levelCEA levelsInvasive carcinomaAntigen levelsCEA stainingIntraductal papillary mucinous neoplasm subtypesPancreatic intraductal papillary mucinous neoplasmsIntraductal papillary mucinous neoplasmPresence of dysplasiaPapillary mucinous neoplasmGrade of dysplasiaRisk of malignancySize of lesionsDuct involvementPathologic variablesCystic lesionsIPMN casesMucinous neoplasmsMucinous secretionHistopathologic correlationNeoplasm subtypesCarcinomaGlycoprotein expressionSignificant correlationDysplasia
2009
Molecular markers and death from prostate cancer.
Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK. Molecular markers and death from prostate cancer. Annals Of Internal Medicine 2009, 150: 595-603. PMID: 19414838, DOI: 10.7326/0003-4819-150-9-200905050-00005.Peer-Reviewed Original ResearchConceptsProstate-specific antigen levelProstate cancerLong-term riskAntigen levelsMicrovessel densityMedian prostate-specific antigen levelIncreased long-term riskVeterans Affairs Healthcare SystemIncident prostate cancerObservational cohort studyProportional hazards analysisTime of diagnosisHigher microvessel densityVeterans Health AdministrationBcl-2Years of ageProstate cancer biopsiesClinical care recordsClinical characteristicsCohort studyPatient ageMedian ageComorbid conditionsHistologic gradeResidual confounding
2007
Molecular markers and mortality in prostate cancer
Concato J, Jain D, Li WW, Risch HA, Uchio EM, Wells CK. Molecular markers and mortality in prostate cancer. BJU International 2007, 100: 1259-1263. PMID: 17850375, DOI: 10.1111/j.1464-410x.2007.07136.x.Peer-Reviewed Original ResearchConceptsProstate cancerPrognostic factorsMedical recordsMicrovessel densityMedian prostate-specific antigen levelProstate-specific antigen levelVeterans Affairs Medical CenterIncident prostate cancerLong-term mortalityCommunity-based populationPotential prognostic factorsTraditional prognostic factorsHigher microvessel densityTraditional clinical factorsAvailable medical recordsIndependent effectsBcl-2 stainingClinical factorsIndependent predictorsMedian ageOverall mortalityAdjusted analysisAntigen levelsMedical CenterAmbulatory care